Exclusive: Novartis drug struck off cancer drugs fund | Pharmafile
Novartis
Novartis generics unit admits to fixing drug prices | Financial Times
Novartis leaps into hydroxychloroquine fray with new phase III study | 2020-04-20 | BioWorld
Anticancer medicine of Novartis, Dabrafenib to get approval for additional indication in India | PharmaTutor
Novartis wins approval for world's most expensive drug | Financial Times
Novartis Allopathic 4mg Sintrom Tablets, Grade Standard: Medicine Grade, Packaging Type: Box at Rs 217/box in Nagpur
With NICE backing, Novartis' Entresto sees more European love | Fierce Pharma
Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo | Fierce Pharma
Novartis, US drug regulator agree to malaria drug trial against COVID-19 - Health - The Jakarta Post
Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion - WSJ
Natco Pharma: Natco dares Novartis with new heart drug
Novartis's No Profit COVID19 Drugs To Low-Income Countries
Novartis' arthritis drug fails to meet endpoints in Covid-19 trial
AMLODIPINE 5MG NOVARTIS | Rocket Health
Novartis
Sandoz spin-off could open door to new litigation against Novartis - JUVE Patent
Voltaren 25 Mg and 100 Mg. Diclofenac Sodium Product of Novartis Editorial Photography - Image of brochure, blister: 124751722
FDA nod for Novartis sets up cholesterol drug showdown with Amgen, Regeneron - MedCity News
novartis: Novartis heart drug price may fall by 60% on generic rollouts - The Economic Times
Novartis and Amgen come to blows over migraine partnership - PMLiVE
Novartis to Swallow Up The Medicines Company for $9.7 Billion - TheStreet
Novartis reportedly nears deal to buy cholesterol drugmaker Medicines Company for $7 billion
Yuyu Pharma to supply 5 Novartis drugs in Korea < Pharma < Article - KBR
Cataflam 25 Mg. Diclofenac Potassium Product of Novartis. Manufactured by Novartis, Turkey for Novatis Pharma, Switzerland Editorial Stock Photo - Image of nonsteroid, advertise: 132903878
